Jemal A, et al. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90.
Article
PubMed
Google Scholar
Farhood B, Geraily G, Alizadeh A. Incidence and mortality of various cancers in Iran and compare to other countries: a review article. Iran J Public Health. 2018;47(3):309–16.
PubMed
PubMed Central
Google Scholar
Mousavi SM, et al. Cancer incidence and mortality in Iran. Ann Oncol. 2009;20(3):556–63.
Article
CAS
PubMed
Google Scholar
Almasi Z, Rafiemanesh H, Salehiniya H. Epidemiology characteristics and trends of incidence and morphology of stomach cancer in Iran. Asian Pac J Cancer Prev. 2015;16(7):2757–61.
Article
PubMed
Google Scholar
Rohani-Rasaf M, et al. Correlation of cancer incidence with diet, smoking and socio-economic position across 22 districts of Tehran in 2008. Asian Pac J Cancer Prev. 2013;14(3):1669–766.
Article
PubMed
Google Scholar
Forouzanfar MH, et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1659–724.
Article
Google Scholar
Plummer M, et al. Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Glob Health. 2016;4(9):e609–e616616.
Article
PubMed
Google Scholar
Hosseini M, et al. Environmental risk factors for lung cancer in Iran: a case-control study. Int J Epidemiol. 2009;38(4):989–96.
Article
PubMed
Google Scholar
Rastaghi S, et al. Trends and risk factors of gastric cancer in Iran (2005–2010). Int J Prev Med. 2019;10:79–79.
Article
PubMed
PubMed Central
Google Scholar
Abbaszadegan MR, Keyvani V, Moghbeli M. Genetic and molecular bases of esophageal cancer among Iranians: an update. Diagn Pathol. 2019;14(1):97.
Article
PubMed
PubMed Central
Google Scholar
Abbaszadegan MR, Moghbeli M. Genetic and molecular origins of colorectal cancer among the Iranians: an update. Diagn Pathol. 2018;13(1):97.
Article
CAS
PubMed
PubMed Central
Google Scholar
Moghbeli M. Genetic and molecular biology of breast cancer among Iranian patients. J Transl Med. 2019;17(1):218.
Article
PubMed
PubMed Central
Google Scholar
Nafissi N, et al. Epidemiology and histopathology of breast cancer in Iran versus other Middle Eastern countries. Middle East J Cancer. 2015;9(3):243–51.
Google Scholar
Sharma S, Kelly TK, Jones PA. Epigenetics in cancer. Carcinogenesis. 2010;31(1):27–36.
Article
CAS
PubMed
Google Scholar
Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet. 2002;3(6):415–28.
Article
CAS
PubMed
Google Scholar
Taft RJ, et al. Non-coding RNAs: regulators of disease. J Pathol. 2010;220(2):126–39.
Article
CAS
PubMed
Google Scholar
Wang C, et al. LncRNA structural characteristics in epigenetic regulation. Int J Mol Sci. 2017;18(12):2659.
Article
PubMed Central
CAS
Google Scholar
Ponting CP, Oliver PL, Reik W. Evolution and functions of long noncoding RNAs. Cell. 2009;136(4):629–41.
Article
CAS
PubMed
Google Scholar
Beroukhim R, et al. The landscape of somatic copy-number alteration across human cancers. Nature. 2010;463(7283):899–905.
Article
CAS
PubMed
PubMed Central
Google Scholar
Melton C, et al. Recurrent somatic mutations in regulatory regions of human cancer genomes. Nat Genet. 2015;47(7):710–6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Guo H, et al. Modulation of long noncoding RNAs by risk SNPs underlying genetic predispositions to prostate cancer. Nat Genet. 2016;48(10):1142–50.
Article
CAS
PubMed
Google Scholar
Majidinia M, Yousefi B. Long non-coding RNAs in cancer drug resistance development. DNA Repair. 2016;45:25–33.
Article
CAS
PubMed
Google Scholar
Zhao X, et al. The rs6983267 SNP and long non-coding RNA CARLo-5 are associated with endometrial carcinoma. Environ Mol Mutagen. 2016;57(7):508–15.
Article
CAS
PubMed
Google Scholar
Akers JC, et al. Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies. J Neurooncol. 2013;113(1):1–11.
Article
PubMed
PubMed Central
Google Scholar
Bolha L, Ravnik-Glavac M, Glavac D. Long noncoding RNAs as biomarkers in cancer. Dis Markers. 2017;2017:7243968.
Article
PubMed
PubMed Central
CAS
Google Scholar
Reis EM, Verjovski-Almeida S. Perspectives of long non-coding RNAs in cancer diagnostics. Front Genet. 2012;3:32.
CAS
PubMed
PubMed Central
Google Scholar
Tang H, et al. Salivary lncRNA as a potential marker for oral squamous cell carcinoma diagnosis. Mol Med Rep. 2013;7(3):761–6.
Article
CAS
PubMed
Google Scholar
Silva A, Bullock M, Calin G. The clinical relevance of long non-coding RNAs in cancer. Cancers. 2015;7(4):2169–82.
Article
CAS
PubMed
PubMed Central
Google Scholar
Mizrahi A, et al. Development of targeted therapy for ovarian cancer mediated by a plasmid expressing diphtheria toxin under the control of H19 regulatory sequences. J Transl Med. 2009;7:69.
Article
PubMed
PubMed Central
CAS
Google Scholar
Ariel I, et al. The imprinted H19 gene is a marker of early recurrence in human bladder carcinoma. Mol Pathol. 2000;53(6):320–3.
Article
CAS
PubMed
PubMed Central
Google Scholar
Yang Z, et al. Overexpression of long non-coding RNA HOTAIR predicts tumor recurrence in hepatocellular carcinoma patients following liver transplantation. Ann Surg Oncol. 2011;18(5):1243–50.
Article
PubMed
Google Scholar
Tsai MC, Spitale RC, Chang HY. Long intergenic noncoding RNAs: new links in cancer progression. Cancer Res. 2011;71(1):3–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Beltran M, et al. A natural antisense transcript regulates Zeb2/Sip1 gene expression during Snail1-induced epithelial–mesenchymal transition. Genes Dev. 2008;22(6):756–69.
Article
CAS
PubMed
PubMed Central
Google Scholar
Amaral PP, et al. Complex architecture and regulated expression of the Sox2ot locus during vertebrate development. RNA. 2009;15(11):2013–27.
Article
CAS
PubMed
PubMed Central
Google Scholar
Askarian-Amiri ME, et al. Emerging role of long non-coding RNA SOX2OT in SOX2 regulation in breast cancer. PLoS ONE. 2014;9(7):e102140.
Article
PubMed
PubMed Central
CAS
Google Scholar
Qu F, Cao P. Long noncoding RNA SOX2OT contributes to gastric cancer progression by sponging miR-194-5p from AKT2. Exp Cell Res. 2018;369(2):187–96.
Article
CAS
PubMed
Google Scholar
Shahryari A, et al. Two novel splice variants of SOX2OT, SOX2OT-S1, and SOX2OT-S2 are coupregulated with SOX2 and OCT4 in esophageal squamous cell carcinoma. Stem Cells. 2014;32(1):126–34.
Article
CAS
PubMed
Google Scholar
Wu Y, et al. Overexpression of long non-coding RNA SOX2OT promotes esophageal squamous cell carcinoma growth. Cancer Cell Int. 2018;18:76–76.
Article
PubMed
PubMed Central
CAS
Google Scholar
Loewer S, et al. Large intergenic non-coding RNA-RoR modulates reprogramming of human induced pluripotent stem cells. Nat Genet. 2010;42(12):1113–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gao S, et al. ROR functions as a ceRNA to regulate Nanog expression by sponging miR-145 and predicts poor prognosis in pancreatic cancer. Oncotarget. 2016;7(2):1608–18.
Article
PubMed
Google Scholar
Zhang A, et al. The human long non-coding RNA-RoR is a p53 repressor in response to DNA damage. Cell Res. 2013;23(3):340–50.
Article
CAS
PubMed
Google Scholar
Takahashi K, et al. Extracellular vesicle-mediated transfer of long non-coding RNA ROR modulates chemosensitivity in human hepatocellular cancer. FEBS Open Bio. 2014;4:458–67.
Article
CAS
PubMed
PubMed Central
Google Scholar
Fan J, et al. Long non-coding RNA ROR decoys gene-specific histone methylation to promote tumorigenesis. Genome Biol. 2015;16(1):139–139.
Article
PubMed
PubMed Central
CAS
Google Scholar
Wang Y, et al. Endogenous miRNA sponge lincRNA-RoR regulates Oct4, Nanog, and Sox2 in human embryonic stem cell self-renewal. Dev Cell. 2013;25(1):69–80.
Article
CAS
PubMed
Google Scholar
Rezaei M, et al. Altered expression of LINC-ROR in cancer cell lines and tissues. Tumor Biology. 2016;37(2):1763–9.
Article
CAS
PubMed
Google Scholar
Wang L, et al. Linc-ROR promotes esophageal squamous cell carcinoma progression through the derepression of SOX9. J Exp Clin Cancer Res. 2017;36(1):182.
Article
PubMed
PubMed Central
CAS
Google Scholar
Hou P, et al. LincRNA-ROR induces epithelial-to-mesenchymal transition and contributes to breast cancer tumorigenesis and metastasis. Cell Death Dis. 2014;5(6):e1287–e12871287.
Article
CAS
PubMed
PubMed Central
Google Scholar
Jiang F, Zhou X, Huang J. Long non-coding RNA-ROR mediates the reprogramming in cardiac hypertrophy. PLoS ONE. 2016;11(4):e0152767.
Article
PubMed
PubMed Central
CAS
Google Scholar
Sahebi R, et al. Linc-ROR and its spliced variants 2 and 4 are significantly up-regulated in esophageal squamous cell carcinoma. Iran J Basic Med Sci. 2016;19(10):1131–5.
PubMed
PubMed Central
Google Scholar
Liu X, Cui L, Liu J. Increased LincRNA ROR is association with poor prognosis for esophageal squamous cell carcinoma patients. Int J Clin Exp Pathol. 2017;10:4654–60.
CAS
Google Scholar
Rahimnia H, et al. Overexpression of long non-coding RNA POU3F3 in esophageal squamous cell carcinoma is associated with TNM stage and family history. J Clin Basic Res. 2018;2(4):48–53.
Article
Google Scholar
Tong Y-S, et al. Identification of the long non-coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma. Mol Cancer. 2015;14(1):3.
Article
PubMed
PubMed Central
CAS
Google Scholar
Shan T-D, et al. Knockdown of linc-POU3F3 suppresses the proliferation, apoptosis, and migration resistance of colorectal cancer. Oncotarget. 2016;7(1):961–75.
Article
PubMed
Google Scholar
Liu HP, et al. Long noncoding RNA PCAT-1 promoted ovarian cancer cell proliferation and invasion by suppressing KLF6. Eur Rev Med Pharmacol Sci. 2019;23(11):4650–5.
PubMed
Google Scholar
Wang Y, et al. Long noncoding RNA PCAT-1 accelerates the metastasis of pancreatic cancer by repressing RBM5. Eur Rev Med Pharmacol Sci. 2019;23(17):7350–5.
CAS
PubMed
Google Scholar
Razavi M, Ghorbian S. Up-regulation of long non-coding RNA-PCAT-1 promotes invasion and metastasis in esophageal squamous cell carcinoma. EXCLI journal. 2019;18:422–8.
PubMed
PubMed Central
Google Scholar
Shi W-H, et al. Upregulation of the long noncoding RNA PCAT-1 correlates with advanced clinical stage and poor prognosis in esophageal squamous carcinoma. Tumor Biol. 2015;36(4):2501–7.
Article
CAS
Google Scholar
Bayat H, et al. Two long non-coding RNAs, Prcat17.3 and Prcat38, could efficiently discriminate benign prostate hyperplasia from prostate cancer. Prostate. 2018;78(11):812–8.
Article
CAS
PubMed
Google Scholar
Hajjari M, Salavaty A. HOTAIR: an oncogenic long non-coding RNA in different cancers. Cancer Biol Med. 2015;12(1):1–9.
CAS
PubMed
PubMed Central
Google Scholar
Taheri M, et al. HOTAIR genetic variants are associated with prostate cancer and benign prostate hyperplasia in an Iranian population. Gene. 2017;613:20–4.
Article
CAS
PubMed
Google Scholar
Oliveira AI, et al. Influence of HOTAIR rs920778 and rs12826786 genetic variants on prostate cancer risk and progression-free survival. Biomark Med. 2018;12(3):257–64.
Article
CAS
PubMed
Google Scholar
Kotake Y, et al. Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene. Oncogene. 2011;30(16):1956–62.
Article
CAS
PubMed
Google Scholar
Yap KL, et al. Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol Cell. 2010;38(5):662–74.
Article
CAS
PubMed
PubMed Central
Google Scholar
Taheri M, et al. Association of ANRIL gene polymorphisms with prostate cancer and benign prostatic hyperplasia in an Iranian population. Biomark Med. 2017;11(5):413–22.
Article
CAS
PubMed
Google Scholar
Zhao B, et al. Overexpression of lncRNA ANRIL promoted the proliferation and migration of prostate cancer cells via regulating let-7a/TGF-beta1/Smad signaling pathway. Cancer Biomark. 2018;21(3):613–20.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sattarifard H, et al. Association between genetic polymorphisms of long non-coding RNA PRNCR1 and prostate cancer risk in a sample of the Iranian population. Mol Clin Oncol. 2017;7(6):1152–8.
CAS
PubMed
PubMed Central
Google Scholar
Yang L, et al. Upregulation of long non-coding RNA PRNCR1 in colorectal cancer promotes cell proliferation and cell cycle progression. Oncol Rep. 2016;35(1):318–24.
Article
CAS
PubMed
Google Scholar
Cheng D, et al. LncRNA PRNCR1 interacts with HEY2 to abolish miR-448-mediated growth inhibition in non-small cell lung cancer. Biomedicine Pharmacotherapy. 2018;107:1540–7.
Article
CAS
PubMed
Google Scholar
Hong JH, et al. Correlations between genetic polymorphisms in long non-coding RNA PRNCR1 and gastric cancer risk in a Korean population. Int J Mol Sci. 2019;20(13):3355.
Article
PubMed Central
Google Scholar
Li L, et al. Association between polymorphisms in long non-coding RNA PRNCR1 in 8q24 and risk of gastric cancer. Tumor Biol. 2016;37(1):299–303.
Article
CAS
Google Scholar
AlMutairi M, et al. Association between polymorphisms in PRNCR1 and risk of colorectal cancer in the Saudi population. PLoS ONE. 2019;14(9):e0220931.
Article
CAS
PubMed
PubMed Central
Google Scholar
Seitz AK, et al. Profiling of long non-coding RNAs identifies LINC00958 and LINC01296 as candidate oncogenes in bladder cancer. Sci Rep. 2017;7(1):395.
Article
PubMed
PubMed Central
CAS
Google Scholar
Yuan W, et al. Comprehensive analysis of lncRNA-associated ceRNA network in colorectal cancer. Biochem Biophys Res Commun. 2019;508(2):374–9.
Article
CAS
PubMed
Google Scholar
Tano K, et al. MALAT-1 enhances cell motility of lung adenocarcinoma cells by influencing the expression of motility-related genes. FEBS Lett. 2010;584(22):4575–80.
Article
CAS
PubMed
Google Scholar
Wu Y, et al. Long noncoding RNA MALAT1: insights into its biogenesis and implications in human disease. Curr Pharm Des. 2015;21(34):5017–28.
Article
CAS
PubMed
Google Scholar
Yoshimoto R, et al. MALAT1 long non-coding RNA in cancer. Biochim Biophys Acta. 2016;1859(1):192–9.
Article
CAS
PubMed
Google Scholar
Tripathi V, et al. The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol Cell. 2010;39(6):925–38.
Article
CAS
PubMed
PubMed Central
Google Scholar
Schmidt LH, et al. Prognostic impact of bcl-2 depends on tumor histology and expression of MALAT-1 lncRNA in non-small-cell lung cancer. J Thorac Oncol. 2014;9(9):1294–304.
Article
CAS
PubMed
Google Scholar
Luan W, et al. Long non-coding RNA MALAT1 acts as a competing endogenous RNA to promote malignant melanoma growth and metastasis by sponging miR-22. Oncotarget. 2016;7(39):63901–12.
Article
PubMed
PubMed Central
Google Scholar
Li HJ, et al. LncRNA UCA1 promotes mitochondrial function of bladder cancer via the MiR-195/ARL2 signaling pathway. Cell Physiol Biochem. 2017;43(6):2548–61.
Article
CAS
PubMed
Google Scholar
Luo J, et al. LncRNA UCA1 promotes the invasion and EMT of bladder cancer cells by regulating the miR-143/HMGB1 pathway. Oncol Lett. 2017;14(5):5556–62.
PubMed
PubMed Central
Google Scholar
Fan Y, et al. Long non-coding RNA UCA1 increases chemoresistance of bladder cancer cells by regulating Wnt signaling. FEBS J. 2014;281(7):1750–8.
Article
CAS
PubMed
Google Scholar
Yazarlou F, et al. Urinary exosomal expression of long non-coding RNAs as diagnostic marker in bladder cancer. Cancer Manag Res. 2018;10:6357–65.
Article
CAS
PubMed
PubMed Central
Google Scholar
Li C, et al. High expression of long noncoding RNA MALAT1 indicates a poor prognosis and promotes clinical progression and metastasis in bladder cancer. Clin Genitourin Cancer. 2017;15(5):570–6.
Article
PubMed
Google Scholar
Bian Z, et al. LncRNA—UCA1 enhances cell proliferation and 5-fluorouracil resistance in colorectal cancer by inhibiting miR-204-5p. Sci Rep. 2016;6:23892.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hou Z, et al. A long noncoding RNA Sox2ot regulates lung cancer cell proliferation and is a prognostic indicator of poor survival. Int J Biochem Cell Biol. 2014;53:380–8.
Article
CAS
PubMed
Google Scholar
Farhangian P, et al. Differential expression of long non-coding RNA SOX2OT in gastric adenocarcinoma. Cancer Biomark. 2018;23(2):221–5.
Article
CAS
PubMed
Google Scholar
Zou J-H, et al. High expression of long noncoding RNA Sox2ot is associated with the aggressive progression and poor outcome of gastric cancer. Eur Rev Med Pharmacol Sci. 2016;20:4482–6.
PubMed
Google Scholar
Zhang Y, et al. LncRNA Sox2ot overexpression serves as a poor prognostic biomarker in gastric cancer. Am J Transl Res. 2016;8(11):5035–43.
CAS
PubMed
PubMed Central
Google Scholar
Hajjari M, et al. Up-regulation of HOTAIR long non-coding RNA in human gastric adenocarcinoma tissues. Med Oncol. 2013;30(3):670.
Article
PubMed
CAS
Google Scholar
Emadi-Andani E, et al. Association of HOTAIR expression in gastric carcinoma with invasion and distant metastasis. Adv Biomed Res. 2014;3:135–135.
Article
PubMed
PubMed Central
CAS
Google Scholar
Xu Z, et al. The association of HOTAIR with the diagnosis and prognosis of gastric cancer and its effect on the proliferation of gastric cancer cells. Can J Gastroenterol Hepatol. 2019;2019:3076345.
PubMed
PubMed Central
Google Scholar
Lu X, et al. The long noncoding RNA HOTAIR promotes colorectal cancer progression by sponging miR-197. Oncol Res. 2018;26(3):473–81.
Article
PubMed
PubMed Central
Google Scholar
Luo Z-F, et al. Clinical significance of HOTAIR expression in colon cancer. World J Gastroenterol. 2016;22(22):5254–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Katsushima K, et al. Targeting the Notch-regulated non-coding RNA TUG1 for glioma treatment. Nat Commun. 2016;7:13616.
Article
PubMed
PubMed Central
Google Scholar
Niu Y, et al. Long non-coding RNA TUG1 is involved in cell growth and chemoresistance of small cell lung cancer by regulating LIMK2b via EZH2. Mol Cancer. 2017;16(1):5.
Article
PubMed
PubMed Central
CAS
Google Scholar
Baratieh Z, et al. Aberrant expression of PlncRNA-1 and TUG1: potential biomarkers for gastric cancer diagnosis and clinically monitoring cancer progression. Biomark Med. 2017;11(12):1077–90.
Article
CAS
PubMed
Google Scholar
Dong L, et al. Upregulation of long non-coding RNA PlncRNA-1 promotes metastasis and induces epithelial-mesenchymal transition in hepatocellular carcinoma. Cell Physiol Biochem. 2016;38(2):836–46.
Article
CAS
PubMed
Google Scholar
Zhang E, et al. Increased expression of long noncoding RNA TUG1 predicts a poor prognosis of gastric cancer and regulates cell proliferation by epigenetically silencing of p57. Cell Death Dis. 2016;7(2):e2109.
Article
CAS
PubMed
PubMed Central
Google Scholar
Guo X, et al. GAS5 inhibits gastric cancer cell proliferation partly by modulating CDK6. Oncol Res Treat. 2015;38(7–8):362–6.
Article
CAS
PubMed
Google Scholar
Liu Y, et al. Long non-coding RNA GAS5 inhibits migration and invasion in gastric cancer via interacting with p53 protein. Dig Liver Dis. 2019. https://doi.org/10.1016/j.dld.2019.08.012.
Article
PubMed
PubMed Central
Google Scholar
Liu Y, et al. lncRNA GAS5 enhances G1 cell cycle arrest via binding to YBX1 to regulate p21 expression in stomach cancer. Sci Rep. 2015;5:10159.
Article
PubMed
PubMed Central
Google Scholar
Aminian K, et al. A functional genetic variant in GAS5 lncRNA (rs145204276) modulates p27Kip1 expression and confers risk for gastric cancer. Br J Biomed Sci. 2019;76(2):83–5.
Article
CAS
PubMed
Google Scholar
Li Q, et al. Polymorphism in the promoter region of lncRNA GAS5 is functionally associated with the risk of gastric cancer. Clin Res Hepatol Gastroenterol. 2018;42(5):478–82.
Article
CAS
PubMed
Google Scholar
Zhao X, et al. Gas5 exerts tumor-suppressive functions in human glioma cells by targeting miR-222. Mol Ther. 2015;23(12):1899–911.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kangarlouei R, et al. ANRIL and ANRASSF1 long noncoding RNAs are upregulated in gastric cancer. J Cell Biochem. 2019;120(8):12544–8.
Article
CAS
PubMed
Google Scholar
Guan H, et al. Downregulation of lncRNA ANRIL suppresses growth and metastasis in human osteosarcoma cells. Oncotargets Ther. 2018;11:4893–9.
Article
Google Scholar
Zhao W, Luo J, Jiao S. Comprehensive characterization of cancer subtype associated long non-coding RNAs and their clinical implications. Sci Rep. 2014;4:6591.
Article
CAS
PubMed
PubMed Central
Google Scholar
Yi L, et al. Long noncoding RNA PTPRG-AS1 acts as a microRNA-194-3p sponge to regulate radiosensitivity and metastasis of nasopharyngeal carcinoma cells via PRC1. J Cell Physiol. 2019;234(10):19088–102.
CAS
PubMed
Google Scholar
Taheri M, Ghafouri-Fard S. Antisense non-coding RNA in the INK4 locus (ANRIL) in human cancers. Int J Cancer Manag. 2018;11(10):e67864.
Google Scholar
Iranpour M, et al. Expression analysis of four long noncoding RNAs in breast cancer. Tumor Biol. 2016;37(3):2933–40.
Article
CAS
Google Scholar
Meseure D, et al. Expression of ANRIL-polycomb complexes-CDKN2A/B/ARF genes in breast tumors: identification of a two-gene (EZH2/CBX7) signature with independent prognostic value. Mol Cancer Res. 2016;14(7):623–33.
Article
CAS
PubMed
Google Scholar
Xu C, et al. Long noncoding RNA PTPRG-AS1 regulates growth of glioma cells by sponging miR-185-5p. RSC Adv. 2019;9(19):10870–80.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hassanzarei S, et al. Genetic polymorphisms of HOTAIR gene are associated with the risk of breast cancer in a sample of southeast Iranian population. Tumour Biol. 2017;39(10):1010428317727539.
Article
PubMed
CAS
Google Scholar
Bayram S, et al. Effect of HOTAIR rs920778 polymorphism on breast cancer susceptibility and clinicopathologic features in a Turkish population. Tumour Biol. 2015;36(5):3863–70.
Article
CAS
PubMed
Google Scholar
Yang F, et al. Up-regulated long non-coding RNA H19 contributes to proliferation of gastric cancer cells. FEBS J. 2012;279(17):3159–65.
Article
CAS
PubMed
Google Scholar
Hou J, et al. Long noncoding RNA H19 upregulates vascular endothelial growth factor A to enhance mesenchymal stem cells survival and angiogenic capacity by inhibiting miR-199a-5p. Stem Cell Res Ther. 2018;9(1):109.
Article
PubMed
PubMed Central
CAS
Google Scholar
Hassanzarei S, et al. Genetic polymorphisms in long noncoding RNA H19 are associated with breast cancer susceptibility in Iranian population. Meta Gene. 2017;14:1–5.
Article
Google Scholar
Safari MR, et al. Genomic variants within the long non-coding RNA H19 confer risk of breast cancer in Iranian population. Gene. 2019;701:121–4.
Article
CAS
PubMed
Google Scholar
Abdollahzadeh S, Ghorbian S. Association of the study between LncRNA-H19 gene polymorphisms with the risk of breast cancer. J Clin Lab Anal. 2019;33(3):e22826.
Article
PubMed
CAS
Google Scholar
Lin Y, et al. Genetic variants in long noncoding RNA H19 contribute to the risk of breast cancer in a southeast China Han population. Onco Targets Ther. 2017;10:4369–78.
Article
PubMed
PubMed Central
Google Scholar
Qin W, et al. Functional polymorphisms of the lncRNA H19 promoter region contribute to the cancer risk and clinical outcomes in advanced colorectal cancer. Cancer Cell Int. 2019;19:215–215.
Article
PubMed
PubMed Central
CAS
Google Scholar
Li L, et al. Association between H19 SNP rs217727 and lung cancer risk in a Chinese population: a case control study. BMC Med Genet. 2018;19(1):136.
Article
PubMed
PubMed Central
CAS
Google Scholar
Adriaenssens E, et al. H19 Overexpression in breast adenocarcinoma stromal cells is associated with tumor values and steroid receptor status but independent of p53 and Ki-67 expression. Am J Pathol. 1998;153(5):1597–607.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sheng L, et al. New insights into the long non-coding RNA SRA: physiological functions and mechanisms of action. Front Med. 2018;5:244–244.
Article
Google Scholar
Kino T, et al. Noncoding RNA Gas5 is a growth arrest- and starvation-associated repressor of the glucocorticoid receptor. Sci Signal. 2010;3(107):ra8.
PubMed
PubMed Central
Google Scholar
Wang L, et al. Down-regulation of lncRNA GAS5 attenuates neuronal cell injury through regulating miR-9/FOXO3 axis in cerebral ischemic stroke. RSC Adv. 2019;9(28):16158–66.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sasaki YTF, et al. MENε/β noncoding RNAs are essential for structural integrity of nuclear paraspeckles. Proc Natl Acad Sci. 2009;106(8):2525–30.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhang P, et al. The lncRNA Neat1 promotes activation of inflammasomes in macrophages. Nat Commun. 2019;10(1):1495.
Article
PubMed
PubMed Central
CAS
Google Scholar
Arshi A, et al. Expression analysis of MALAT1, GAS5, SRA, and NEAT1 lncRNAs in breast cancer tissues from young women and women over 45 years of age. Mol Ther Nucleic Acids. 2018;12:751–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Huang XJ, et al. MALAT1 promotes angiogenesis of breast cancer. Oncol Rep. 2018;40(5):2683–9.
CAS
PubMed
Google Scholar
Li S, et al. Long noncoding RNA GAS5 suppresses triple negative breast cancer progression through inhibition of proliferation and invasion by competitively binding miR-196a-5p. Biomed Pharmacother. 2018;104:451–7.
Article
CAS
PubMed
Google Scholar
Yan R, et al. Genetic variants in lncRNA SRA and risk of breast cancer. Oncotarget. 2016;7(16):22486–96.
Article
PubMed
PubMed Central
Google Scholar
Shin VY, et al. Long non-coding RNA NEAT1 confers oncogenic role in triple-negative breast cancer through modulating chemoresistance and cancer stemness. Cell Death Dis. 2019;10(4):270.
Article
PubMed
PubMed Central
CAS
Google Scholar
Soleimanpour E, et al. Evaluating long non-coding RNA PRNCR1 in breast cancer. J Fasa Univ Med Sci. 2018;8(1):637–46.
Google Scholar
Babaei E, Hoseinpour Feizi MA. Study of the differential expression of non-coding RNA, such as PRNCR1, in the plasma of breast cancer patients. Sci J Ilam Univ Med Sci. 2019;26(5):71–8.
Google Scholar
Kholdi S, et al. Non-coding RNA NAV2-AS2 and the risk of lobular carcinoma in breast. Biomed Health. 2018;3(1):46–53.
Google Scholar
Ravanbakhsh R, et al. Clinical and in vitro study of novel long non-coding RNA lncUSMycN in breast cancer. Iran Biomed J. 2018;23:303–11.
Article
Google Scholar
Gong H, et al. High expression of long non-coding RNA ZEB1-AS1 promotes colorectal cancer cell proliferation partially by suppressing p15 expression. Tumour Biol. 2017;39(6):1010428317705336.
PubMed
Google Scholar
Rezanejad Bardaji H, Asadi MH, Yaghoobi MM. Long non-coding RNA ZEB1-AS1 promotes tumorigenesis and metastasis in colorectal cancer. J Genet Resour. 2018;4(1):1–6.
Google Scholar
Lv S-Y, et al. The lncRNA ZEB1-AS1 sponges miR-181a-5p to promote colorectal cancer cell proliferation by regulating Wnt/β-catenin signaling. Cell Cycle. 2018;17(10):1245–54.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kazemzadeh M, et al. Misregulation of the dependence receptor DCC and its upstream lincRNA, LOC100287225, in colorectal cancer. Tumori J. 2015;103(1):40–3.
Article
CAS
Google Scholar
Kazemzadeh M, et al. LOC100287225, novel long intergenic non-coding RNA, misregulates in colorectal cancer. Cancer Biomark. 2016;16(3):499–505.
Article
CAS
PubMed
Google Scholar
Rezanejad Bardaji H, Asadi MH, Yaghoobi MM. Long noncoding RNA VIM-AS1 promotes colorectal cancer progression and metastasis by inducing EMT. Eur J Cell Biol. 2018;97(4):279–88.
Article
CAS
PubMed
Google Scholar
Gong J, et al. A functional polymorphism in lnc-LAMC2-1:1 confers risk of colorectal cancer by affecting miRNA binding. Carcinogenesis. 2016;37(5):443–51.
Article
CAS
PubMed
Google Scholar
Hashemi M, et al. Association of lnc-LAMC2-1:1 rs2147578 and CASC8 rs10505477 polymorphisms with risk of childhood acute lymphoblastic leukemia. Asian Pac J Cancer Prev. 2016;17(11):4985–9.
PubMed
PubMed Central
Google Scholar
Deng J, et al. Long non-coding RNA OIP5-AS1 functions as an oncogene in lung adenocarcinoma through targeting miR-448/Bcl-2. Biomed Pharmacother. 2018;98:102–10.
Article
CAS
PubMed
Google Scholar
Kim J, et al. LncRNA OIP5-AS1/cyrano sponges RNA-binding protein HuR. Nucleic Acids Res. 2016;44(5):2378–92.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhang J, et al. LncRNA OIP5-AS1 promotes the proliferation of hemangioma vascular endothelial cells via regulating miR-195-5p/NOB1 axis. Front Pharmacol. 2019;10:449.
Article
PubMed
PubMed Central
CAS
Google Scholar
Esfandi F, et al. Expression analysis of OIP5-AS1 in non-small cell lung cancer. Klin Onkol. 2018;31(4):260–3.
Article
PubMed
Google Scholar
Wang M, et al. Long non-coding RNA OIP5-AS1 promotes proliferation of lung cancer cells and leads to poor prognosis by targeting miR-378a-3p. Thorac Cancer. 2018;9(8):939–49.
Article
CAS
PubMed
PubMed Central
Google Scholar